Are there any generic drugs that compete with camzyos?

Are there generic (or biosimilar) drugs that compete with Camzyos (mavacamten)?

Camzyos contains mavacamten. At the time of the information provided here, there are no generic versions of mavacamten listed as available competitors to Camzyos, because the drug is still within its protected period in key markets due to patent/exclusivity constraints.

Why no generic mavacamten yet?

Generic approval typically requires a pathway that depends on patent and exclusivity status. Camzyos’s protected status means companies generally cannot market a generic version of mavacamten until relevant patents and exclusivity windows expire or are successfully challenged.

Are there any “near” competitors instead of generics?

Even if no generic Camzyos exists, patients and clinicians may be treated with other available therapies for the same condition (hypertrophic cardiomyopathy). Those are therapeutic competitors, but they are not generics of mavacamten.

If you tell me which country you care about (for example, U.S., EU, U.K.), I can narrow the answer to the generics status and the exact legal/patent timeline in that market using DrugPatentWatch.com.

Sources:
1. DrugPatentWatch.com